Register
Login:
Share:
Email Facebook Twitter


London South East - Oil & Gas Investor Evening: Malcy, Echo, Savannah, SDX
Paul Welch speaks at London South East's Oil & Gas Investor Evening


Plethora Solutions Holdings PLC Share Price (PLE)



Share Price Information for Plethora Solutions Holdings PLC (PLE)


There is currently no data for Plethora Solutions Holdings PLC.




London South East Users info for Plethora Solutions Holdings PLC





View more Plethora Solutions Holdings PLC trades >>

Directors Deals for Plethora Solutions Holdings PLC (PLE)
Trade DateActionNotifierPriceCurrencyAmountHolding
28-Oct-15Notification of Holding
Trade Notifier Information for Plethora Solutions Holdings
James (Jim) Mellon held the position of Chairman at Plethora Solutions Holdings at the time of this trade.
 James (Jim) Mellon
00243758261
01-Apr-15Notification of Holding
Trade Notifier Information for Plethora Solutions Holdings
James (Jim) Mellon held the position of Chairman at Plethora Solutions Holdings at the time of this trade.
 James (Jim) Mellon
00246613861
29-Jan-15Notification of Holding
Trade Notifier Information for Plethora Solutions Holdings
James (Jim) Mellon held the position of Chairman at Plethora Solutions Holdings at the time of this trade.
 James (Jim) Mellon
00145974014
View more Plethora Solutions Holdings PLC directors dealings >>


Alquemie
Posts: 984
Opinion:No Opinion
Price:0.00
RE: Sales progress update due soon...
Today 17:33
Recordati never disclose actual sales for anything other than their lead franchise (>5% of turnover) products so I would not hope for an update on Fortacin before the RP interim report.

Fortacin doesn't even get a mention in the last corporate presentation as a new product launch, although that's in keeping with past minor product launches (Vitaros/Virirec, for example), and there's a palpable shift in corporate emphasis towards the orphan and rare disease pipeline.

And, to repeat a point I've made before, the disclosed sales of 21.000 canisters or so is just that- bookable sales made to wholesalers and not an indicator of prescription volume. With such a small treatment population, it's going to take a while for wholesaler held inventory to find its way off the shelves, so don't be surprised if the number of canisters sold since launch does not change much in the next update.

Always difficult to predict the sales trajectory of a non-reimbursed product, the only certainty being that it's much flatter than for reimbursed products. The true story with respect to sales dynamics might not become clear until at least three years from launch. It's no coincidence that Recordati opted for the delta between RP's estimate and actual sales after three years as the trigger for the clawback arrangement.
The.Italian
Posts: 360
Premium Chat Member
Opinion:No Opinion
Price:0.00
greece and romania
Today 17:31
I've found bigness post which mentions that we were scheduled to launch in greece and romania in september .is there any way we can check to see if anything has actually happened?
bunion
Posts: 351
Opinion:Buy
Price:0.00
RE: Sales progress update due soon...
Today 10:37
70,000.........and ever increasing........as you say, early days....but we have the professionals of Recordati on the job across Europe, not a couple of bods in Hong Kong
The.Italian
Posts: 360
Premium Chat Member
Opinion:No Opinion
Price:0.00
RE: Sales progress update due soon...
Today 10:35
good morning pikeypete and matt.as the share price will be looking after itself i hope it has had adequate training in resucitation techniques and intensive care.

good point matt about Recordati results but not confident that we will get any sales progress updates as a result .however i hope we do and if so I'm going for 40000 units although i would hope for more.im sure bignose posted recently that there were 2/3 more european countries due to have launched by now but no update from regent so who knows
MattD78
Posts: 350
Opinion:No Opinion
Price:0.00
Sales progress update due soon...
Today 09:58
Excluding the share price debacle, good morning to all.

This time next week Recordati are likely (based on previous years) to announce their 3rd quarter results. We should then get an idea how much traction there has been since launch, followed by the reaction in HK after the weekend. It may be then that an update from RP will be issued as we start to go into November and few would believe we’d be this low at this point in the journey. Initial launch was about 21,000 units in 3 to 4 months. Anyone want to guess and predict possible units from end June? I’m going to guess just for curiosity at just under 50,000 units and see what gets announced. Some patients will continue and there should in theory be additional patients on board and more clinicians and sales reps promoting it. It is still early stages for traction but I’d be interested what others would guess as being sold, and it is a curious guess to pass the time in anticipation of progress.
View more share chat for Plethora Solutions Holdings PLC (PLE) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.